Martin J. Murphy was Founding CEO and Board Director of the CEO Roundtable on Cancer at the request of the late 41st President George H.W. Bush. He served on the board until named Emeritus Board Director in January 2021. He also was Founding CEO of Project Data Sphere® (PDS).
Dr. Murphy now is Chief Executive Officer of the non-profit Shanghai TuoXin Health Promotion Center that has expanded its purview from cancer prevention and improving cancer patient outcomes to include international Covid-19 interventions and global pandemic preparedness.
He is the founding Executive Editor of the peer-reviewed journal, The Oncologist ; Founding Editor of Stem Cells; and Co-Founder of its sister journal, Stem Cells Translational Medicine. He co-chairs the Scientific & Strategic Advisory Council of the International COVID-19 Data Alliance of the Bill & Melinda Gates Foundation.
An NIH principal investigator, Dr. Murphy is co-founder of the Society for Translational Oncology, member of six Scientific Advisory Boards, Chairman Emeritus of Conquer Cancer –ASCO Foundation, and Steering Member of Chinese Society of Clinical Oncology. He is an emeritus member of the National Cancer Policy Forum of National Academy of Medicine (US National Academy of Sciences), member of Center for Public Health Advisory Board, Milken Institute, emeritus director of Foundation for NIH, Fellow of American Society of Clinical Oncology, and former vice chairman of C-Change.